Ser89

Site Information
ELAsALksALsGHLE SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 17400937

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	lung cancer ( 1 ) , non-small cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:	Calu 6 (pulmonary) ( 1 ) , H2009 (pulmonary) ( 1 ) , H2077 (pulmonary) ( 1 ) , H2887 (pulmonary) ( 1 ) , H322M (pulmonary) ( 1 ) , HCC2279 (pulmonary) ( 1 ) , HCC366 (pulmonary) ( 1 ) , HCC78 (pulmonary) ( 1 ) , HOP62 (pulmonary) ( 1 ) , NCI-H157 (pulmonary) ( 1 ) , NCI-H1648 (pulmonary) ( 1 ) , NCI-H1666 (pulmonary) ( 1 ) , NCI-H2172 (pulmonary) ( 1 ) , NCI-H322 (pulmonary) ( 1 )

References
1	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info
2	Beli P, et al. (2012) Proteomic Investigations Reveal a Role for RNA Processing Factor THRAP3 in the DNA Damage Response. Mol Cell 46, 212-25 22424773 Curated Info